Natalie C Edwards
Overview
Explore the profile of Natalie C Edwards including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
227
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bao Y, Liang H, Zhang P, Wang C, Jiang T, Zhang N, et al.
Chin Med J (Engl)
. 2025 Jan;
138(4):493-495.
PMID: 39820400
No abstract available.
2.
Edwards N, Lao P, Alshikho M, Ericsson O, Rizvi B, Petersen M, et al.
Brain Commun
. 2024 Oct;
6(5):fcae331.
PMID: 39403075
By age 40 years, over 90% of adults with Down syndrome have Alzheimer's disease pathology and most progress to dementia. Despite having few systemic vascular risk factors, individuals with Down...
3.
Monga M, Edwards N, Rojanasarot S, Patel M, Turner E, White J, et al.
J Endourol
. 2024 Jun;
38(8):755-762.
PMID: 38877816
Diffusion of Innovation Theory explains how ideas or products gain momentum and diffuse (or spread) through specific populations or social systems over time. The theory analyzes primary influencers of the...
4.
Rizvi B, Lao P, Sathishkumar M, Taylor L, Queder N, McMillan L, et al.
Brain Commun
. 2024 May;
6(3):fcae157.
PMID: 38764776
Adults with Down syndrome are less likely to have hypertension than neurotypical adults. However, whether blood pressure measures are associated with brain health and clinical outcomes in this population has...
5.
Morales C, Cotton-Samuel D, Lao P, Chang J, Pyne J, Alshikho M, et al.
Alzheimers Res Ther
. 2024 Feb;
16(1):25.
PMID: 38308344
Background: Secondary prevention clinical trials for Alzheimer's disease (AD) target amyloid accumulation in asymptomatic, amyloid-positive individuals, but it is unclear to what extent other pathophysiological processes, such as small vessel...
6.
Edwards N, Lao P, Alshikho M, Ericsson O, Rizvi B, Petersen M, et al.
medRxiv
. 2023 Dec;
PMID: 38076904
Importance: By age 40 years over 90% of adults with Down syndrome (DS) have Alzheimer's disease (AD) pathology and most progress to dementia. Despite having few systemic vascular risk factors,...
7.
Scott M, Edwards N, Properzi M, Jacobs H, Price J, Lois C, et al.
J Cereb Blood Flow Metab
. 2023 Sep;
44(1):131-141.
PMID: 37728659
Clinically normal females exhibit higher F-flortaucipir (FTP)-PET signal than males across the cortex. However, these sex differences may be explained by neuroimaging idiosyncrasies such as off-target extracerebral tracer retention or...
8.
Ben-Zacharia A, Walker B, Ross A, Tornatore C, Edwards N, Lipman Y, et al.
Int J MS Care
. 2023 Sep;
25(5):188-195.
PMID: 37720259
Background: Patients with multiple sclerosis (MS) receiving disease-modifying therapies (DMT) show published adherence rates of 27.0% to 93.8% and published persistence rates of 49.7% to 96.5%. Improvements in DMT adherence...
9.
Khera M, Langston J, Pollard M, Asafu-Adjei D, Edwards N, Nitschelm K, et al.
Urol Pract
. 2023 Aug;
10(5):501-510.
PMID: 37594033
Introduction: A manufacturer's benefit verification database was evaluated to ascertain United States health plan insurance coverage for implantable penile prostheses for erectile dysfunction. Methods: All-payer and employer-sponsored health plan benefit...
10.
Nicholas J, Edwards N, Edwards R, Dellarole A, Manca L, Harlow D, et al.
Mult Scler J Exp Transl Clin
. 2022 Jul;
8(2):20552173221101150.
PMID: 35795102
Background: Increased understanding of adherence may facilitate optimal targeting of interventions. Objective: To utilize group-based trajectory modeling (GBTM) to understand longitudinal patterns of adherence and factors associated with non-adherence in...